Original Research
Published on 09 Jan 2023
Research landscape and trends of melanoma immunotherapy: A bibliometric analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1024179
- 2,590 views
- 5 citations
Type at least 3 characters
1,278 articles
Articles
Review
Published on 09 Jan 2023
Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1054231
- 9,458 views
- 17 citations
Review
Published on 04 Jan 2023
Contribution of natural killer cells in innate immunity against colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1077053
- 3,931 views
- 7 citations
Review
Published on 04 Jan 2023
The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1072739
- 1,766 views
- 4 citations
Review
Published on 04 Jan 2023
Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1077436
- 2,430 views
- 5 citations
Original Research
Published on 04 Jan 2023
CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1048296
- 2,210 views
- 3 citations
Original Research
Published on 22 Dec 2022
PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1055371
- 2,250 views
- 6 citations
Review
Published on 22 Dec 2022
Immune checkpoint blockade for locally advanced or recurrent/metastatic cervical cancer: An update on clinical data
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1045481
- 7,294 views
- 7 citations
Case Report
Published on 22 Dec 2022
Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1065137
- 1,596 views
- 5 citations
Original Research
Published on 22 Dec 2022
Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1081091
- 2,954 views
- 1 citation
Review
Published on 21 Dec 2022
Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC – A systematic review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1089320
- 3,426 views
- 4 citations
Original Research
Published on 20 Dec 2022
Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1015850
- 1,670 views
- 1 citation
Original Research
Published on 20 Dec 2022
Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.975980
- 10,603 views
- 10 citations
Methods
Published on 19 Dec 2022
Spatial heterogeneity of cancer associated protein expression in immunohistochemically stained images as an improved prognostic biomarker
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.964716
- 1,583 views
Original Research
Published on 19 Dec 2022
Comparison of McKeown Minimally Invasive Esophagectomy vs sweet esophagectomy for esophageal squamous cell carcinoma: A retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1009315
- 1,479 views
- 2 citations
Review
Published on 12 Dec 2022
Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.939356
- 4,805 views
- 2 citations